AbbVie (ABBV) Interest & Investment Income (2012 - 2016)
AbbVie (ABBV) posted Interest & Investment Income of $20 million for Q2 2016, up 150.0% from $8 million a year earlier and up 33.3% from the prior quarter.
AbbVie (ABBV) Interest & Investment Income (2012 - 2016) Analysis & Trends
For the trailing twelve months through Jun 30, 2016, Interest & Investment Income at AbbVie was $54 million, up 22.7% year-over-year; for FY2015, it was $33 million, down 13.2% from FY2014.
- Annual Interest & Investment Income shows a four-year compound annual growth rate of 13.3% (FY2011 to FY2015).
- In prior years, AbbVie's Interest & Investment Income was $38 million in FY2014 (+81.0%), $21 million in FY2013 (+5.0%), $20 million in FY2012 (unchanged) and $20 million in FY2011.
- On a year-over-year basis, Interest & Investment Income increased in six of the last eight quarters, with growth averaging 82.5%.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q1 2013, with growth of 500.0%; the weakest was Q3 2015, with a decline of 50.0%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $15 million (Q1 2016), $9 million (Q4 2015) and $10 million (Q3 2015).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | - |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 118.40 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | 20.00 Mn |
| Mar 31, 2016 | 15.00 Mn |
| Dec 31, 2015 | 9.00 Mn |
| Sep 30, 2015 | 10.00 Mn |
| Jun 30, 2015 | 8.00 Mn |
| Mar 31, 2015 | 6.00 Mn |
| Dec 31, 2014 | 10.00 Mn |
| Sep 30, 2014 | 20.00 Mn |
| Jun 30, 2014 | 4.00 Mn |
| Mar 31, 2014 | 5.00 Mn |
| Dec 31, 2013 | 6.00 Mn |
| Sep 30, 2013 | 6.00 Mn |
| Jun 30, 2013 | 4.00 Mn |
| Mar 31, 2013 | 6.00 Mn |
| Dec 31, 2012 | 6.00 Mn |
| Sep 30, 2012 | 11.00 Mn |
| Jun 30, 2012 | 2.00 Mn |
| Mar 31, 2012 | 1.00 Mn |
AbbVie Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ABBV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();